2,015
Views
6
CrossRef citations to date
0
Altmetric
Original Research

PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cells

ORCID Icon, , , ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Article: e1466765 | Received 24 Jul 2017, Accepted 13 Apr 2018, Published online: 31 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ruoheng Zhang, J.D. Neighbors, T.D. Schell & R.J. Hohl. (2022) Schweinfurthin induces ICD without ER stress and caspase activation. OncoImmunology 11:1.
Read now
Mara Gagliardi, Valentina Saverio, Romina Monzani, Eleonora Ferrari, Mauro Piacentini & Marco Corazzari. (2020) Ferroptosis: a new unexpected chance to treat metastatic melanoma?. Cell Cycle 19:19, pages 2411-2425.
Read now
Xiaodan Qin, William D. Denton, Leah N. Huiting, Kaylee S. Smith & Hui Feng. (2020) Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity. Critical Reviews in Biochemistry and Molecular Biology 55:4, pages 322-353.
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now

Articles from other publishers (1)

Paola Giglio, Mara Gagliardi, Roberta Bernardini, Maurizio Mattei, Diego Cotella, Claudio Santoro, Mauro Piacentini & Marco Corazzari. (2018) Ecto-Calreticulin is essential for an efficient immunogenic cell death stimulation in mouse melanoma. Genes & Immunity 20:6, pages 509-513.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.